Hexagon Nutrition’s initial public offering (IPO) received strong investor demand on the final day of bidding, with the issue subscribed 53.68 times overall, driven largely by robust participation from non-institutional investors.
The non-institutional investors (NII) portion was subscribed 161.49 times, while the retail category saw subscription of 26.85 times. The qualified institutional buyers (QIB) segment was bookedt19.77 imes.
The ₹139-crore IPO has a price band of ₹42-45 per equity share. The public issue is entirely an offer-for-sale (OFS) of over 3.08 crore equity shares by promoters. At the upper end of the price band, the issue size is estimated at ₹138.87 crore.
Anchor portion
Ahead of the IPO opening, Hexagon Nutrition raised ₹41.66 crore from anchor investors by allotting 92.57 lakh equity shares at ₹45 apiece.
Bandhan Small Cap Fund was the only domestic mutual fund participant in the anchor book, receiving an allocation of 26.66 lakh shares worth ₹12 crore. Other investors included Ampersand Growth Opportunities Fund Scheme-I, CP Capital Ltd, Visionary Value Fund and Innovative Vision Fund.
Listing date
Hexagon Nutrition said the proposed listing would help enhance visibility, strengthen brand recognition and provide liquidity to existing shareholders. Shares of the company are expected to list on the stock exchanges on June 12.
Founded in 1993, Hexagon Nutrition started as a micronutrient formulations company and later diversified into branded nutrition products. Its portfolio includes brands such as Pentasure, Obesigo and Pediagold across health, wellness and clinical nutrition categories.
The company operates in more than 75 countries and offers products including micronutrient premixes, therapeutic nutrition, clinical nutrition, wellness products and fortified foods.
More Like This
Published on June 9, 2026
